ADMINISTRATIVE AND COMPETING SUPPLEMENTS TO STUDY ISSUES RELATED TOMARIJUANA NIH GUIDE, Volume 24, Number 21, June 9, 1995 P.T. 34 Keywords: Drugs/Drug Abuse Mental Disorders Epidemiology National Institute on Drug Abuse The National Institute on Drug Abuse (NIDA) announces the availability of funds to supplement existing NIH-supported individual research project grants (R01) to study issues related to marijuana, including issues in the context of polysubstance abuse and/or comorbid mental disorders and other diseases, e.g., HIV infection. Research is requested in the following areas: etiology to determine the interaction of multiple biological, genetic, social, psychological, cultural, and environmental factors and processes associated with the initiation and progression of marijuana use and abuse; epidemiology to understand the factors associated with the trends in incidence and prevalence and patterns of marijuana use among various subpopulations including ethnic groups, rural youth, preadolescents, school dropouts; social, psychological, physiological, and health sequelae and consequences of marijuana use; and, assessment of interventions to prevent the initiation and progression of marijuana use and its consequences. Within the area of prevention and treatment, issues that may be addressed included client evaluation, engagement, retention, cost/effectiveness, and family and couples factors. Studies using animal models as well as human subjects both in clinical settings as well as the community are encouraged. Cross-cutting issues that impact marijuana use are strongly recommended to include comparative studies across gender, ethnic groups, and age cohorts. For FY 1995, $250,000 will be available for administrative supplements to existing R01 grants only. These supplements must be within the scope of the parent grant. Administrative supplements will undergo a program, grants management, and budget review within the NIDA. Administrative supplements may be submitted at any time for the remainder of FY 1995, but no later than August 1, 1995; any one award should not be more than 25 percent of the Council-approved direct cost budget for FY 1995 or $100,000, whichever is less. For FY 1996, it is anticipated that approximately $500,000 will be available for both administrative and competing renewal supplements. The competing renewal supplements will be reviewed in accordance with NIH standard review procedures, i.e., peer review/council review. Competing renewal supplement requests must be submitted utilizing the following receipt dates: March 1, July 1 and November 1. Administrative supplements may be submitted any time during the fiscal year, but no later than August 1, 1996. INQUIRIES Zili Sloboda, Ph.D. Division of Epidemiology and Prevention Research National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857 Telephone: (301) 443-6504 Email: zsloboda@aoada@ssw.dhhs.gov .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |